-
Feb 16, 2024 | 
jdsupra.com | Rachel Lamparelli |Scott Memmott
New York expanded its existing efforts at monitoring and understanding prescription drug prices by enacting legislation addressing prescription drug price transparency. Effective June 19, 2024, S.599-A/A.1707 amends the New York Insurance Law to require prescription drug manufacturers to report certain price increases before they occur.
-
Feb 15, 2024 | 
lexology.com | Rachel Lamparelli |Scott Memmott
New York expanded its existing efforts at monitoring and understanding prescription drug prices by enacting legislation addressing prescription drug price transparency. Effective June 19, 2024, S.599-A/A.1707 amends the New York Insurance Law to require prescription drug manufacturers to report certain price increases before they occur.
-
Feb 15, 2024 | 
morganlewis.com | Rachel Lamparelli |Scott Memmott
New York expanded its existing efforts at monitoring and understanding prescription drug prices by enacting legislation addressing prescription drug price transparency. Effective June 19, 2024, S.599-A/A.1707 amends the New York Insurance Law to require prescription drug manufacturers to report certain price increases before they occur.
-
Jan 25, 2024 | 
jdsupra.com | Jacob Harper |Rachel Lamparelli
Digital health—that is, medical care enhanced or made possible by the use of technology—has changed the landscape of healthcare in America. Innovation in this sector is at an all-time high and 2024 will no doubt see greater expansion and acceptance of digital health within the care continuum. Much of the momentum associated with digital health implementation stems from the COVID-19 pandemic and the Public Health Emergency (PHE) declared to address it.
-
Jan 24, 2024 | 
morganlewis.com | Jacob Harper |Rachel Lamparelli
Digital health—that is, medical care enhanced or made possible by the use of technology—has changed the landscape of healthcare in America. Innovation in this sector is at an all-time high and 2024 will no doubt see greater expansion and acceptance of digital health within the care continuum. Much of the momentum associated with digital health implementation stems from the COVID-19 pandemic and the Public Health Emergency (PHE) declared to address it.
-
Nov 6, 2023 | 
jdsupra.com | Felicia Alexander |Jacob Harper |Rachel Lamparelli
The US Centers for Medicare & Medicaid Services (CMS) has implemented a final rule, effective November 13, 2023, designed to enhance the oversight of hospice providers throughout the United States and increase regulatory scrutiny of poor-performing hospices through the Hospice Special Focus Program (SFP). In recent months, CMS has expanded its focus on addressing the significant increase in the number of hospices enrolling in the Medicare program and related program integrity risks.
-
Oct 19, 2023 | 
jdsupra.com | Jacob Harper |Rachel Lamparelli
The US Drug Enforcement Administration (DEA) issued a temporary rule on October 6, 2023 extending COVID-19–era flexibilities through December 31, 2024. With this extension, the DEA will continue to waive provisions under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 that prohibit practitioners from prescribing controlled substances to patients without first conducting an in-person encounter.
-
Oct 18, 2023 | 
morganlewis.com | Jacob Harper |Rachel Lamparelli
The US Drug Enforcement Administration (DEA) issued a temporary rule on October 6, 2023 extending COVID-19–era flexibilities through December 31, 2024. With this extension, the DEA will continue to waive provisions under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 that prohibit practitioners from prescribing controlled substances to patients without first conducting an in-person encounter.
-
Sep 22, 2023 | 
jdsupra.com | Jacob Harper |Rachel Lamparelli
If your organization has faced a Medicare audit in the last decade, you may have experienced a significant delay in the Medicare appeals process due to a monumental backlog of claims pending in front of administrative law judges (ALJs). As a result, the Office of Medicare Hearings and Appeals (OMHA) has initiated several pilot programs and received a significant boost in funding following a federal court decision requiring OMHA to develop a plan to reduce this backlog.
-
Sep 21, 2023 | 
morganlewis.com | Jacob Harper |Rachel Lamparelli
If your organization has faced a Medicare audit in the last decade, you may have experienced a significant delay in the Medicare appeals process due to a monumental backlog of claims pending in front of administrative law judges (ALJs). As a result, the Office of Medicare Hearings and Appeals (OMHA) has initiated several pilot programs and received a significant boost in funding following a federal court decision requiring OMHA to develop a plan to reduce this backlog.
